The arrival of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable excitement within the weight loss community. This groundbreaking dual GIP and GLP-1 target medication appears to offer impressive improvements in weight loss compared to current therapies. Preliminary research studies have demonstrated marked decreases in body mass ,